In this study, the finding that ESRRG expression was higher in SCLC tumors than in the control group and that this higher expression was associated with increased overall survival suggested that ESRRG has the potential to act as a tumor suppressor in SCLC. The gene discussed is ESRRG; the disease is neoplasm.